Clinical response of immunotherapy targeting programmed cell death receptor 1/programmed cell death ligand 1 in advanced signet-ring-cell gastric cancer
The findings suggest that GSRCC is associated with resistance to immunotherapy in advanced GC. Furthermore, peritoneal metastasis is significantly associated with poor prognosis in GSRCC patients.
Authors
- Huayuan Liang
- Jinghua Yu (ORCID: https://orcid.org/0000-0001-5043-0322)
- Jie Liang (ORCID: https://orcid.org/0009-0000-6846-2189)
- Xinhua Chen
- Liying Zhao
Institutions
- Southern Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1080/14796694.2025.2612083
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00